Christopher J. Ryerson

Active 2010–2025

170
Papers
32,186
Citations
69
h-index
162
i10-index

Citations

Citations per year for Christopher J. Ryerson1994: 1 citations2004: 1 citations2007: 3 citations2008: 2 citations2009: 1 citations2010: 1 citations2011: 1 citations2012: 8 citations2013: 32 citations2014: 76 citations2015: 99 citations2016: 104 citations2017: 185 citations2018: 177 citations2019: 946 citations2020: 1,499 citations2021: 1,634 citations2022: 1,301 citations2023: 1,111 citations2024: 1,935 citations2025: 803 citations2026: 31 citations1995–2003: no citations, so these years are not shown2005–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,006 citing papers, 19.3% of this breakdownChina: 998 citing papers, 9.6% of this breakdownUnited Kingdom: 787 citing papers, 7.6% of this breakdownItaly: 733 citing papers, 7% of this breakdownJapan: 591 citing papers, 5.7% of this breakdownGermany: 529 citing papers, 5.1% of this breakdownCanada: 515 citing papers, 5% of this breakdownFrance: 491 citing papers, 4.7% of this breakdownSpain: 321 citing papers, 3.1% of this breakdownAustralia: 311 citing papers, 3% of this breakdownNetherlands: 277 citing papers, 2.7% of this breakdownSouth Korea: 253 citing papers, 2.4% of this breakdown
0%19.3%Other 24.8%

Fields

  • Medicine91.7%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Health Professions1.1%
  • Immunology and Microbiology0.9%
  • Engineering0.8%
  • Environmental Science0.4%
  • Other1.8%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis21.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research5.4%
  • Systemic Sclerosis and Related Diseases5.4%
  • Sarcoidosis and Beryllium Toxicity Research3.8%
  • Inflammatory Myopathies and Dermatomyositis3.3%
  • Long-Term Effects of COVID-192.9%
  • Other57.9%

Coauthors

All papers

Open in search
  1. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Ho, Julie Morisset, Amy L. Olson, Anna Podolanczuk, Venerino Poletti, Moisés Selman, Thomas Ewing, Stephen Jones, Shandra L. Knight, Marya Ghazipura, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2022 cited by 2,618

  2. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 cited by 4,100

  3. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 cited by 4,273

  4. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

    Authors: , , , , , , , , - Pharmacology & Therapeutics 2020 cited by 652

  5. Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa A. Maier, Carlos Matiz, Ferrán Morell, Andrew G. Nicholson, Setu Patolia, Carlos A.C. Pereira, Elisabetta Renzoni, Margaret L. Salisbury, Moisés Selman, Simon Walsh, Wim Wuyts, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2020 cited by 1,012

  6. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 1,444

  7. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 cited by 570

  8. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

    Authors: , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 cited by 1,022

  9. Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 389

  10. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , - Annals of Internal Medicine 2012 cited by 1,313

  11. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy J. Doyle, Anthony H. Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen M. Humphries, John Huntwork, Chris Glynn, Steve Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz‐Odrobina, Reba Bissell, Mark H. Wener, Lisa Lancaster, Leslie J. Crawford, Karmela K Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria Kokosi, Matthew Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie Fletcher, Paul Beirne, C Favager, Jo Brown, Julie Dawson and 7 more - The Lancet Respiratory Medicine 2022 cited by 208

  12. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 223

  13. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 185

  14. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

    Authors: , , , , , , , - European Respiratory Review 2023 cited by 215

  15. Predicting Survival Across Chronic Interstitial Lung Disease

    Authors: , , , , , , , , , , - CHEST Journal 2013 cited by 565

  16. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Radiology 2020 cited by 1,127

  17. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Athol U. Wells - American Journal of Respiratory and Critical Care Medicine 2022 cited by 226

  18. Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 cited by 297

  19. YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis

    Authors: , , , , - Annals of the American Thoracic Society 2019 cited by 163

  20. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 253

  21. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - CHEST Journal 2020 cited by 1,304

  22. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 301

  23. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2024 cited by 65

  24. Progression of fibrosing interstitial lung disease

    Authors: , , - Respiratory Research 2020 cited by 184